During the past decade, Institute of Arthritis Research conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 19 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 13 clinical trials were completed. i.e. 325% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Arthritis Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Genentech, Inc." with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Arthritis Research" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Brigham Young University" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Arthritis Research" are "Rheumatoid Arthritis" (10 trials), "Systemic Lupus Erythematosus" (4 trials), "Arthritis, Rheumatoid" (3 trials), "Axial Spondyloarthritis" (2 trials) and "Chronic Gout" (2 trials). Many other conditions were trialed in "Institute of Arthritis Research" in a lesser frequency.

Most popular intervention types in "Institute of Arthritis Research" are "Drug" (26 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "GDC-0853" (3 trials), "Ixekizumab" (3 trials), "Adalimumab" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Arthritis Research" are 27 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institute of Arthritis Research". 1 are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Institute of Arthritis Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Arthritis Research, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".